4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001193125-26-285567
Chief Legal Officer sold 13,008 shares at $45.03 ($585,750)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Sullivan Mark · Chief Legal Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-25 | Sale : show line 1 in the form 10b5-1 | −13,008 | $45.03 | $585,750 | 320,571 | D |
| Open-market sales · 13,008 sh · avg $45.03 · $585,750 | ||||||
Loading xslF345X06/ownership.xml…